Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico -San Marco" — Catania

Public research footprint of Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico -San Marco", compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

IDH Wild-type and STAT3-positive Glioblastoma · Relapsed Refractory Multiple Myeloma (RRMM) · Acute-graft-versus-host Disease · Phosphomannomutase 2 Deficiency

Recently updated registry entries

NCT05920356 — A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum… (Recruiting)
NCT06872892 — The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With… (Recruiting)
NCT06657859 — Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients (Enrolling By Invitation)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico -San Marco"?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.